Portfolio company
Transforming cells into cures
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cellular Intelligence
This company develops artificial intelligence foundation models to predict cell signaling and design cell therapies for pharmaceutical companies and clinical researchers.
Cellular Origins
The company develops an automated robotic platform for cell therapy developers to manufacture and scale autologous and allogeneic therapies.
Form Bio
This company provides a software platform using artificial intelligence to help biopharmaceutical organisations and researchers design and optimise cell and gene therapies.
CellFE
The company develops microfluidic platforms for intracellular delivery of molecules to support cell therapy developers and researchers in manufacturing engineered cells.
Cellino
The company develops an autonomous biomanufacturing platform to produce personalised stem cell therapies for patients with chronic degenerative diseases.
Techbio 2.0
This company develops induced pluripotent stem cell models and artificial intelligence platforms to provide predictive drug discovery data for pharmaceutical and biotechnology researchers.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Tolemy Bio
This company develops an AI platform to model and optimise cellular behaviour for biotechnology and pharmaceutical organisations developing advanced therapies.
